Cytoimmunologic monitoring in heart transplant patients

G. Ippoliti, A. Gavazzi, G. Bajani, B. Rovati, C. Campana, D. Arrigoni, L. Martinelli, G. Minzioni, A. Graffigna, M. Vigano

Research output: Contribution to journalArticle

Abstract

Cytoimmunologic monitoring (CIM) has been described as a simple and reliable method for detecting an allograft rejection following heart transplant. This method is based on the presence of recirculating sensitized lymphocytes from the transplant, and thus it is possible to identify activated lymphocytes in peripheral blood. Our experience in 41 episodes clearly confirms what was previously reported by others. Thus, CIM may be considered a reliable method in monitoring heart transplant patients both in diagnosis of acute rejection and infectious episodes. We think that using a panel of monoclonal antibodies to early antigen activation may be useful in identifying the beginning of cellular activation, before any morphologic changes are present.

Original languageEnglish
Pages (from-to)770-771
Number of pages2
JournalTransplantation Proceedings
Volume20
Issue number1 SUPPL. 1
Publication statusPublished - 1988

Fingerprint

Transplants
Lymphocytes
Allografts
Monoclonal Antibodies
Antigens

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Ippoliti, G., Gavazzi, A., Bajani, G., Rovati, B., Campana, C., Arrigoni, D., ... Vigano, M. (1988). Cytoimmunologic monitoring in heart transplant patients. Transplantation Proceedings, 20(1 SUPPL. 1), 770-771.

Cytoimmunologic monitoring in heart transplant patients. / Ippoliti, G.; Gavazzi, A.; Bajani, G.; Rovati, B.; Campana, C.; Arrigoni, D.; Martinelli, L.; Minzioni, G.; Graffigna, A.; Vigano, M.

In: Transplantation Proceedings, Vol. 20, No. 1 SUPPL. 1, 1988, p. 770-771.

Research output: Contribution to journalArticle

Ippoliti, G, Gavazzi, A, Bajani, G, Rovati, B, Campana, C, Arrigoni, D, Martinelli, L, Minzioni, G, Graffigna, A & Vigano, M 1988, 'Cytoimmunologic monitoring in heart transplant patients', Transplantation Proceedings, vol. 20, no. 1 SUPPL. 1, pp. 770-771.
Ippoliti G, Gavazzi A, Bajani G, Rovati B, Campana C, Arrigoni D et al. Cytoimmunologic monitoring in heart transplant patients. Transplantation Proceedings. 1988;20(1 SUPPL. 1):770-771.
Ippoliti, G. ; Gavazzi, A. ; Bajani, G. ; Rovati, B. ; Campana, C. ; Arrigoni, D. ; Martinelli, L. ; Minzioni, G. ; Graffigna, A. ; Vigano, M. / Cytoimmunologic monitoring in heart transplant patients. In: Transplantation Proceedings. 1988 ; Vol. 20, No. 1 SUPPL. 1. pp. 770-771.
@article{4969814f6f354b37b8a9c550c89d5090,
title = "Cytoimmunologic monitoring in heart transplant patients",
abstract = "Cytoimmunologic monitoring (CIM) has been described as a simple and reliable method for detecting an allograft rejection following heart transplant. This method is based on the presence of recirculating sensitized lymphocytes from the transplant, and thus it is possible to identify activated lymphocytes in peripheral blood. Our experience in 41 episodes clearly confirms what was previously reported by others. Thus, CIM may be considered a reliable method in monitoring heart transplant patients both in diagnosis of acute rejection and infectious episodes. We think that using a panel of monoclonal antibodies to early antigen activation may be useful in identifying the beginning of cellular activation, before any morphologic changes are present.",
author = "G. Ippoliti and A. Gavazzi and G. Bajani and B. Rovati and C. Campana and D. Arrigoni and L. Martinelli and G. Minzioni and A. Graffigna and M. Vigano",
year = "1988",
language = "English",
volume = "20",
pages = "770--771",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "1 SUPPL. 1",

}

TY - JOUR

T1 - Cytoimmunologic monitoring in heart transplant patients

AU - Ippoliti, G.

AU - Gavazzi, A.

AU - Bajani, G.

AU - Rovati, B.

AU - Campana, C.

AU - Arrigoni, D.

AU - Martinelli, L.

AU - Minzioni, G.

AU - Graffigna, A.

AU - Vigano, M.

PY - 1988

Y1 - 1988

N2 - Cytoimmunologic monitoring (CIM) has been described as a simple and reliable method for detecting an allograft rejection following heart transplant. This method is based on the presence of recirculating sensitized lymphocytes from the transplant, and thus it is possible to identify activated lymphocytes in peripheral blood. Our experience in 41 episodes clearly confirms what was previously reported by others. Thus, CIM may be considered a reliable method in monitoring heart transplant patients both in diagnosis of acute rejection and infectious episodes. We think that using a panel of monoclonal antibodies to early antigen activation may be useful in identifying the beginning of cellular activation, before any morphologic changes are present.

AB - Cytoimmunologic monitoring (CIM) has been described as a simple and reliable method for detecting an allograft rejection following heart transplant. This method is based on the presence of recirculating sensitized lymphocytes from the transplant, and thus it is possible to identify activated lymphocytes in peripheral blood. Our experience in 41 episodes clearly confirms what was previously reported by others. Thus, CIM may be considered a reliable method in monitoring heart transplant patients both in diagnosis of acute rejection and infectious episodes. We think that using a panel of monoclonal antibodies to early antigen activation may be useful in identifying the beginning of cellular activation, before any morphologic changes are present.

UR - http://www.scopus.com/inward/record.url?scp=0023899776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023899776&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0023899776

VL - 20

SP - 770

EP - 771

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 1 SUPPL. 1

ER -